{"count": 68, "results": [{"_id": "37805878", "pmid": 37805878, "title": "MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022.", "journal": "Georgian Med News", "authors": ["Stepaniuk N", "Piniazhko O", "Poshyvak O", "Bessarab T", "Hudz N", "Gavriluk I"], "date": "2023-07-01T00:00:00Z", "meta_date_publication": "2023 Jul-Aug", "meta_volume": "", "meta_issue": "340-341", "meta_pages": "76-80", "score": 50239.996, "text_hl": "In the category of CCB drugs, @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (66%) and @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ (20%) held the leading positions. among angiotensin-converting enzyme inhibitors, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ caused the most prevalent and predicted adverse reaction, that of @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@, affecting 10.5% of patients, whereas, with the combination therapy of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@, the @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ was observed in only 5.2% of patients. ", "citations": {"NLM": "Stepaniuk N, Piniazhko O, Poshyvak O, Bessarab T, Hudz N, Gavriluk I. MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022. Georgian Med News. 2023 Jul-Aug;(340-341):76-80. PMID: 37805878", "BibTeX": "@article{37805878, title={MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022.}, author={Stepaniuk N and Piniazhko O and Poshyvak O and Bessarab T and Hudz N and Gavriluk I}, journal={Georgian Med News}, number={340-341}, pages={76-80}}"}}, {"_id": "3022268", "pmid": 3022268, "title": "Clarification of lisinopril cough.", "journal": "Postgrad Med", "authors": ["Nash DT"], "date": "1986-11-01T00:00:00Z", "meta_date_publication": "1986 Nov 1", "meta_volume": "80", "meta_issue": "6", "meta_pages": "46", "score": 50104.984, "text_hl": "Clarification of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@.", "citations": {"NLM": "Nash DT. Clarification of lisinopril cough. Postgrad Med. 1986 Nov 1;80(6):46. PMID: 3022268", "BibTeX": "@article{3022268, title={Clarification of lisinopril cough.}, author={Nash DT}, journal={Postgrad Med}, volume={80}, number={6}, pages={46}}"}}, {"_id": "10344620", "pmid": 10344620, "title": "Losartan-induced cough after lisinopril therapy.", "journal": "Am J Health Syst Pharm", "authors": ["Conigliaro RL", "Gleason PP"], "date": "1999-05-01T00:00:00Z", "doi": "10.1093/ajhp/56.9.914", "meta_date_publication": "1999 May 1", "meta_volume": "56", "meta_issue": "9", "meta_pages": "914-5", "score": 50091.387, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@-induced @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ after @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy.", "citations": {"NLM": "Conigliaro RL, Gleason PP. Losartan-induced cough after lisinopril therapy. Am J Health Syst Pharm. 1999 May 1;56(9):914-5. PMID: 10344620", "BibTeX": "@article{10344620, title={Losartan-induced cough after lisinopril therapy.}, author={Conigliaro RL and Gleason PP}, journal={Am J Health Syst Pharm}, volume={56}, number={9}, pages={914-5}}"}}, {"_id": "10832502", "pmid": 10832502, "title": "Losartan-induced cough after lisinopril therapy.", "journal": "Am J Health Syst Pharm", "authors": ["Conigliaro RL", "Gleason PP"], "date": "2000-05-15T00:00:00Z", "doi": "10.1093/ajhp/57.10.996", "meta_date_publication": "2000 May 15", "meta_volume": "57", "meta_issue": "10", "meta_pages": "996-7", "score": 50090.99, "text_hl": "@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@-induced @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ after @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy.", "citations": {"NLM": "Conigliaro RL, Gleason PP. Losartan-induced cough after lisinopril therapy. Am J Health Syst Pharm. 2000 May 15;57(10):996-7. PMID: 10832502", "BibTeX": "@article{10832502, title={Losartan-induced cough after lisinopril therapy.}, author={Conigliaro RL and Gleason PP}, journal={Am J Health Syst Pharm}, volume={57}, number={10}, pages={996-7}}"}}, {"_id": "1346451", "pmid": 1346451, "title": "Female sex as an important determinant of lisinopril-induced cough.", "journal": "Lancet", "authors": ["Os I", "Bratland B", "Dahlöf B", "Gisholt K", "Syvertsen JO", "Tretli S"], "date": "1992-02-08T00:00:00Z", "doi": "10.1016/0140-6736(92)91694-4", "meta_date_publication": "1992 Feb 8", "meta_volume": "339", "meta_issue": "8789", "meta_pages": "372", "score": 50090.605, "text_hl": "Female sex as an important determinant of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-induced @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@.", "citations": {"NLM": "Os I, Bratland B, Dahlöf B, Gisholt K, Syvertsen JO, Tretli S. Female sex as an important determinant of lisinopril-induced cough. Lancet. 1992 Feb 8;339(8789):372. PMID: 1346451", "BibTeX": "@article{1346451, title={Female sex as an important determinant of lisinopril-induced cough.}, author={Os I and Bratland B and Dahlöf B and Gisholt K and Syvertsen JO and Tretli S}, journal={Lancet}, volume={339}, number={8789}, pages={372}}"}}, {"_id": "7848615", "pmid": 7848615, "title": "Female preponderance for lisinopril-induced cough in hypertension.", "journal": "Am J Hypertens", "authors": ["Os I", "Bratland B", "Dahlöf B", "Gisholt K", "Syvertsen JO", "Tretli S"], "date": "1994-11-01T00:00:00Z", "doi": "10.1093/ajh/7.11.1012", "meta_date_publication": "1994 Nov", "meta_volume": "7", "meta_issue": "11", "meta_pages": "1012-5", "score": 50087.812, "text_hl": "Female preponderance for @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-induced @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@.", "citations": {"NLM": "Os I, Bratland B, Dahlöf B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens. 1994 Nov;7(11):1012-5. PMID: 7848615", "BibTeX": "@article{7848615, title={Female preponderance for lisinopril-induced cough in hypertension.}, author={Os I and Bratland B and Dahlöf B and Gisholt K and Syvertsen JO and Tretli S}, journal={Am J Hypertens}, volume={7}, number={11}, pages={1012-5}}"}}, {"_id": "8092546", "pmid": 8092546, "title": "ACE inhibitors and cough.", "journal": "Angiology", "authors": ["Yeşil S", "Yeşil M", "Bayata S", "Postaci N"], "date": "1994-09-01T00:00:00Z", "doi": "10.1177/000331979404500908", "meta_date_publication": "1994 Sep", "meta_volume": "45", "meta_issue": "9", "meta_pages": "805-8", "score": 50085.2, "text_hl": "In conclusion, although @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ may occur with all four types of ACE inhibitors, the incidence of this side effect was higher during @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ and @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@ treatment than during @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ treatment. ", "citations": {"NLM": "Yeşil S, Yeşil M, Bayata S, Postaci N. ACE inhibitors and cough. Angiology. 1994 Sep;45(9):805-8. PMID: 8092546", "BibTeX": "@article{8092546, title={ACE inhibitors and cough.}, author={Yeşil S and Yeşil M and Bayata S and Postaci N}, journal={Angiology}, volume={45}, number={9}, pages={805-8}}"}}, {"_id": "8583482", "pmid": 8583482, "title": "ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.", "journal": "J Hum Hypertens", "authors": ["Ramsay LE", "Yeo WW"], "date": "1995-11-01T00:00:00Z", "meta_date_publication": "1995 Nov", "meta_volume": "9 Suppl 5", "meta_issue": "", "meta_pages": "S51-4", "score": 50085.145, "text_hl": "The specific selective AT1 angiotensin II receptor antagonist @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ is significantly less likely than @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ to cause @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ in @SPECIES_9606 @@@patients@@@ who previously have had ACE inhibitor @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@. ", "citations": {"NLM": "Ramsay LE, Yeo WW. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. J Hum Hypertens. 1995 Nov;9 Suppl 5():S51-4. PMID: 8583482", "BibTeX": "@article{8583482, title={ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group.}, author={Ramsay LE and Yeo WW}, journal={J Hum Hypertens}, volume={9 Suppl 5}, pages={S51-4}}"}}, {"_id": "1668546", "pmid": 1668546, "title": "[Cough induced by angiotensin converting enzyme inhibitors: report of a case by lysinopril].", "journal": "AMB Rev Assoc Med Bras", "authors": ["Feder D", "Romaldini H"], "date": "1991-07-01T00:00:00Z", "meta_date_publication": "1991 Jul-Sep", "meta_volume": "37", "meta_issue": "3", "meta_pages": "160", "score": 50084.91, "text_hl": "[@<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@Cough@@@ induced by angiotensin converting enzyme inhibitors: report of a case by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lysinopril@@@].", "citations": {"NLM": "Feder D, Romaldini H. [Cough induced by angiotensin converting enzyme inhibitors: report of a case by lysinopril]. AMB Rev Assoc Med Bras. 1991 Jul-Sep;37(3):160. PMID: 1668546", "BibTeX": "@article{1668546, title={[Cough induced by angiotensin converting enzyme inhibitors: report of a case by lysinopril].}, author={Feder D and Romaldini H}, journal={AMB Rev Assoc Med Bras}, volume={37}, number={3}, pages={160}}"}}, {"_id": "9473956", "pmid": 9473956, "title": "An open trial of lisinopril ('ZESTRIL') in mild to moderate hypertension in Nigeria.", "journal": "West Afr J Med", "authors": ["Abengowe CU", "Ezedinachi EN", "Balogun MO"], "date": "1997-10-01T00:00:00Z", "meta_date_publication": "1997 Oct-Dec", "meta_volume": "16", "meta_issue": "4", "meta_pages": "218-22", "score": 50080.29, "text_hl": "Of the 46 evaluable @SPECIES_9606 @@@patients@@@, 32 (70%) had their blood pressure controlled (i.e. diastolic blood pressure < or = 90 Hg). @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ ('@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Zestril@@@') was well tolerated, with 27% of @SPECIES_9606 @@@patients@@@ reporting adverse reactions of which @<m>DISEASE_Cough</m> @DISEASE_MESH:D003371 @@@cough@@@ was the most common. ", "citations": {"NLM": "Abengowe CU, Ezedinachi EN, Balogun MO. An open trial of lisinopril ('ZESTRIL') in mild to moderate hypertension in Nigeria. West Afr J Med. 1997 Oct-Dec;16(4):218-22. PMID: 9473956", "BibTeX": "@article{9473956, title={An open trial of lisinopril ('ZESTRIL') in mild to moderate hypertension in Nigeria.}, author={Abengowe CU and Ezedinachi EN and Balogun MO}, journal={West Afr J Med}, volume={16}, number={4}, pages={218-22}}"}}]}